Amwell (NYSE: AMWL) reported Q1 EPS of ($0.26), $0.03 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $64.2 million versus the consensus estimate of $64.94 million.

GUIDANCE:

Amwell sees FY2022 revenue of $275-285 million.

For earnings history and earnings-related data on Amwell (AMWL) click here.